RT @CCR_AACR: Attending the Major Symposium T Cells and the Tumor #AACR23 and want more from Dr. Katelyn Byrne @PennMedicine @PennCancer ?…
937 followers
6,819 followers
RT @CCR_AACR: Attending the Major Symposium T Cells and the Tumor #AACR23 and want more from Dr. Katelyn Byrne @PennMedicine @PennCancer ?…
6,820 followers
Attending the Major Symposium T Cells and the Tumor #AACR23 and want more from Dr. Katelyn Byrne @PennMedicine @PennCancer ? You might be interested in the data from this interesting clinical trial. https://t.co/OsRRycgsDK https://t.co/YkCnebk8cC
6,820 followers
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. https://t.co/GQHhtJAMjt. #AACRtii20 https://t.co/v4HSw70wAr